These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1. Archelos JJ; Mäurer M; Jung S; Miyasaka M; Tamatani T; Toyka KV; Hartung HP Lab Invest; 1994 May; 70(5):667-75. PubMed ID: 8196363 [TBL] [Abstract][Full Text] [Related]
3. Suppression of experimental autoimmune neuritis by leflunomide. Korn T; Toyka K; Hartung HP; Jung S Brain; 2001 Sep; 124(Pt 9):1791-802. PubMed ID: 11522581 [TBL] [Abstract][Full Text] [Related]
4. Resistance and susceptibility to experimental autoimmune neuritis in Sprague-Dawley and Lewis rats correlate with different levels of autoreactive T and B cell responses to myelin antigens. Zhu J; Zou LP; Bakhiet M; Mix E J Neurosci Res; 1998 Nov; 54(3):373-81. PubMed ID: 9819142 [TBL] [Abstract][Full Text] [Related]
5. Neurophysiological changes in demyelinating and axonal forms of acute experimental autoimmune neuritis in the Lewis rat. Taylor JM; Pollard JD Muscle Nerve; 2003 Sep; 28(3):344-52. PubMed ID: 12929195 [TBL] [Abstract][Full Text] [Related]
6. Inflammation and proinflammatory cytokine production, but no demyelination of facial nerves, in experimental autoimmune neuritis in Lewis rats. Zhu W; Mix E; Zhu J J Neuroimmunol; 2003 Jul; 140(1-2):97-101. PubMed ID: 12864976 [TBL] [Abstract][Full Text] [Related]
7. Differential susceptibility to experimental autoimmune neuritis in Lewis rat strains is associated with T-cell immunity to myelin antigens. Zhu W; Zhang K; Mix E; Wang X; Adem A; Zhu J J Neurosci Res; 2011 Mar; 89(3):448-56. PubMed ID: 21259331 [TBL] [Abstract][Full Text] [Related]
8. Modulation of experimental autoimmune neuritis in Lewis rats by oral application of myelin antigens. Gaupp S; Hartung HP; Toyka K; Jung S J Neuroimmunol; 1997 Nov; 79(2):129-37. PubMed ID: 9394785 [TBL] [Abstract][Full Text] [Related]
9. Therapeutic effect of transforming growth factor-beta 2 on actively induced EAN but not adoptive transfer EAN. Jung S; Schluesener HJ; Schmidt B; Fontana A; Toyka KV; Hartung HP Immunology; 1994 Dec; 83(4):545-51. PubMed ID: 7533133 [TBL] [Abstract][Full Text] [Related]
10. Accumulation of immunoglobulin across the 'blood-nerve barrier' in spinal roots in adoptive transfer experimental autoimmune neuritis. Hadden RD; Gregson NA; Gold R; Smith KJ; Hughes RA Neuropathol Appl Neurobiol; 2002 Dec; 28(6):489-97. PubMed ID: 12445165 [TBL] [Abstract][Full Text] [Related]
11. Morphologic study on experimental allergic neuritis mediated by T cell line specific for bovine P2 protein in Lewis rats. Izumo S; Linington C; Wekerle H; Meyermann R Lab Invest; 1985 Aug; 53(2):209-18. PubMed ID: 2410663 [TBL] [Abstract][Full Text] [Related]
12. Adoptive transfer-experimental allergic neuritis in newborn Lewis rats results in inflammatory infiltrates, mast cell activation, and increased Ia expression with only minor nerve fiber degeneration. Pilartz M; Jess T; Indefrei D; Schröder JM Acta Neuropathol; 2002 Nov; 104(5):513-24. PubMed ID: 12410399 [TBL] [Abstract][Full Text] [Related]
13. Tissue resident macrophages are sufficient for demyelination during peripheral nerve myelin induced experimental autoimmune neuritis? Taylor JM J Neuroimmunol; 2017 Dec; 313():69-76. PubMed ID: 29153611 [TBL] [Abstract][Full Text] [Related]
14. Prevention of experimental autoimmune neuritis by nasal administration of P2 protein peptide 57-81. Zhu J; Deng GM; Levi M; Wahren B; Diab A; van der Meide PH; Link H J Neuropathol Exp Neurol; 1998 Mar; 57(3):291-301. PubMed ID: 9600221 [TBL] [Abstract][Full Text] [Related]
15. Adoptive transfer of experimental allergic neuritis in the immune suppressed host. Hahn AF; Feasby TE; Lovgren D; Wilkie L Acta Neuropathol; 1993; 86(6):596-601. PubMed ID: 7508670 [TBL] [Abstract][Full Text] [Related]
16. Increased lipocortin-1 (annexin-1) expression in the sciatic nerve of Lewis rats with experimental autoimmune neuritis. Gold R; Oelschläger M; Pepinsky RB; Sommer C; Hartung HP; Toyka KV Acta Neuropathol; 1999 Dec; 98(6):583-9. PubMed ID: 10603033 [TBL] [Abstract][Full Text] [Related]
17. Prevention and therapy of experimental autoimmune neuritis by an antibody against T cell receptors-alpha/beta. Jung S; Krämer S; Schluesener HJ; Hünig T; Toyka K; Hartung HP J Immunol; 1992 Jun; 148(12):3768-75. PubMed ID: 1376340 [TBL] [Abstract][Full Text] [Related]
18. Time Course of Axon and Myelin Degeneration in Peripheral Nerves in Experimental Autoimmune Neuritis Rats. Tomikawa E; Mutsuga M; Hara K; Kaneko C; Togashi Y; Miyamoto Y Toxicol Pathol; 2019 Jun; 47(4):542-552. PubMed ID: 30987532 [TBL] [Abstract][Full Text] [Related]
19. Distribution of inducible nitric oxide synthase and tumor necrosis factor-alpha in the peripheral nervous system of Lewis rats during ascending paresis and spontaneous recovery from experimental autoimmune neuritis. De La Hoz CL; Castro FR; Santos LM; Langone F Neuroimmunomodulation; 2010; 17(1):56-66. PubMed ID: 19816058 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory role. Pelidou SH; Zou LP; Deretzi G; Oniding C; Mix E; Zhu J Exp Neurol; 2000 May; 163(1):165-72. PubMed ID: 10785455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]